###begin article-title 0
###xml 22 23 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 28 32 28 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
Antigen-sensitized CD4+CD62Llow memory/effector T helper 2 cells can induce airway hyperresponsiveness in an antigen free setting
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 306 311 <span type="species:ncbi:10090">mouse</span>
Airway hyperresponsiveness (AHR) is one of the most prominent features of asthma, however, precise mechanisms for its induction have not been fully elucidated. We previously reported that systemic antigen sensitization alone directly induces AHR before development of eosinophilic airway inflammation in a mouse model of allergic airway inflammation, which suggests a critical role of antigen-specific systemic immune response itself in the induction of AHR. In the present study, we examined this possibility by cell transfer experiment, and then analyzed which cell source was essential for this process.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 7 11 <span type="species:ncbi:10090">mice</span>
###xml 91 95 <span type="species:ncbi:10090">mice</span>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
BALB/c mice were immunized with ovalbumin (OVA) twice. Spleen cells were obtained from the mice and were transferred in naive mice. Four days later, AHR was assessed. We carried out bronchoalveolar lavage (BAL) to analyze inflammation and cytokine production in the lung. Fluorescence and immunohistochemical studies were performed to identify T cells recruiting and proliferating in the lung or in the gut of the recipient. To determine the essential phenotype, spleen cells were column purified by antibody-coated microbeads with negative or positive selection, and transferred. Then, AHR was assessed.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 622 631 622 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 644 646 644 646 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 718 719 718 719 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 724 728 724 728 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 54 58 <span type="species:ncbi:10090">mice</span>
###xml 142 146 <span type="species:ncbi:10090">mice</span>
###xml 540 544 <span type="species:ncbi:10090">mice</span>
Transfer of spleen cells obtained from OVA-sensitized mice induced a moderate, but significant, AHR without airway antigen challenge in naive mice without airway eosinophilia. Immunization with T helper (Th) 1 elicited antigen (OVA with complete Freund's adjuvant) did not induce the AHR. Transferred cells distributed among organs, and the cells proliferated in an antigen free setting for at least three days in the lung. This transfer-induced AHR persisted for one week. Interleukin-4 and 5 in the BAL fluid increased in the transferred mice. Immunoglobulin E was not involved in this transfer-induced AHR. Transfer of in vitro polarized CD4+ Th2 cells, but not Th1 cells, induced AHR. We finally clarified that CD4+CD62Llow memory/effector T cells recruited in the lung and proliferated, thus induced AHR.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 213 215 213 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
These results suggest that antigen-sensitized memory/effector Th2 cells themselves play an important role for induction of basal AHR in an antigen free, eosinophil-independent setting. Therefore, regulation of CD4+ T cell-mediated immune response itself could be a critical therapeutic target for allergic asthma.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 181 182 181 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 330 331 330 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 332 333 332 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 551 552 551 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 553 554 553 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 555 556 555 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 643 644 643 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 645 647 645 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 670 675 670 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 847 848 847 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 968 969 968 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 955 960 <span type="species:ncbi:10090">mouse</span>
Bronchial asthma is a chronic disorder characterized as reversible airway obstruction, eosinophilic airway inflammation, mucus hypersecretion, and airway hyperresponsiveness (AHR) [1]. In the process of airway inflammation, various types of cells, such as eosinophils, mast cells, T lymphocytes, and dendritic cells are involved [2,3]. AHR to nonspecific stimuli is a hallmark of asthma. However, the precise mechanism to induce AHR has not been fully elucidated. Persistence of eosinophilic airway inflammation is closely linked to induction of AHR [1,4,5]. However, the dissociation of AHR and eosinophilic airway inflammation often occurs [6-12]. For example, Leckie et al. showed that administration of neutralizing antibody (Ab) to interleukin (IL) -5 does not suppress AHR despite this treatment abrogating eosinophilia in blood and sputum [6]. In addition, even a protective role of eosinophils on the AHR induction has been recently proposed in a mouse model [9]. These findings suggest that other mechanism(s) than eosinophilic inflammation would be involved in inducing AHR.
###end p 11
###begin p 12
###xml 77 79 77 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 178 180 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 281 283 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 284 286 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 314 316 314 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 412 414 412 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 415 417 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 471 473 471 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 571 573 571 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 22 30 <span type="species:ncbi:9606">patients</span>
###xml 191 196 <span type="species:ncbi:10090">mouse</span>
###xml 337 341 <span type="species:ncbi:10090">mice</span>
On the other hand, in patients with asthma, activated T cells, especially CD4+ T helper (Th) 2 cells, also infiltrate into the airway, which is associated with disease severity [13-15]. In a mouse model, administration of blocking Ab to CD4 suppresses AHR and airway inflammation [11,16]. Moreover, transfer of CD4+ Th2 cells into naive mice and subsequent antigen-inhalation induce AHR and airway inflammation [17,18]. These findings suggest that T cells, especially CD4+ Th2 cells, are also important for the AHR induction. However, in these studies, AHR induced by CD4+ Th2 cells accompanies eosinophilic airway inflammation. Therefore, it remains unclear whether T cells alone could directly induce AHR.
###end p 12
###begin p 13
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
We previously reported that systemic antigen sensitization alone directly induces AHR before development of eosinophilic inflammation in mice [19]. This raised a possibility that systemic immune response to antigen itself could directly induce AHR.
###end p 13
###begin p 14
###xml 387 388 387 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 393 397 393 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 255 259 <span type="species:ncbi:10090">mice</span>
The purpose of the present study was to investigate which component in the immunocompetent cells could directly induce AHR. In this study, we found that passive cell transfer of spleen cells obtained after antigen-sensitization reconstituted AHR in naive mice. Then, using this system, we studied the cell source essential for the AHR induction, and confirmed that antigen-sensitized CD4+CD62Llow memory/effector Th2 cells would play an essential role for induction of basal AHR.
###end p 14
###begin title 15
Methods
###end title 15
###begin title 16
###xml 16 20 <span type="species:ncbi:10090">mice</span>
Immunization of mice and transfer of spleen cells
###end title 16
###begin p 17
###xml 44 46 44 46 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 47 49 47 49 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 163 166 163 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4</italic>
###xml 166 172 166 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tm2Nnt</italic>
###xml 166 172 166 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>tm2Nnt</italic></sup>
###xml 903 904 901 902 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 912 913 910 911 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 921 922 919 920 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 933 935 931 933 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7 </sup>
###xml 995 996 993 994 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 85 89 <span type="species:ncbi:10090">mice</span>
###xml 150 154 <span type="species:ncbi:10090">mice</span>
###xml 297 303 <span type="species:ncbi:9913">bovine</span>
###xml 467 471 <span type="species:ncbi:10090">mice</span>
###xml 565 569 <span type="species:ncbi:10090">mice</span>
###xml 666 669 <span type="species:ncbi:31658">CFA</span>
###xml 891 895 <span type="species:ncbi:10090">mice</span>
###xml 983 987 <span type="species:ncbi:10090">mice</span>
###xml 1087 1091 <span type="species:ncbi:10090">mice</span>
Mice were immunized as reported previously [19,20]. Seven-week-old male BALB/cAnNCrj mice (Charles River Japan, Kanagawa, Japan) or IL-4 gene-deleted mice (BALB/c-IL4tm2Nnt; Jackson Laboratory, Bar Harbor, ME) were sensitized with an i.p. injection of 2 mug ovalbumin (OVA; Sigma, St. Louis, MO), bovine serum albumin (BSA; Wako, Osaka, Japan), or keyhole limpet hemocyanin (KLH; Calbiochem, LaJolla, CA) plus 2 mg aluminum hydroxide (alum) on days 0 and 11. Control mice received an injection of physiologic saline (SA) without alum on days 0 and 11. Some control mice received an injection of SA plus alum. In some experiments, we used complete Freund's adjuvant (CFA; Difco Laboratories, Detroit, MI) instead of alum as an adjuvant. On day 18, cell suspensions of spleens were obtained by pressing the tissues through a 70-mum nylon filters. Spleen cells prepared from the OVA-sensitized mice (1 x 106, 5 x 106, 2 x 107, or 5 x 107 in 0.5 ml HBSS, respectively) or the SA-treated mice (5 x 107) were transferred into syngenic recipients by intravenous injection. In some experiments, mice were sensitized with OVA on days 0 and 11, and then challenged with 3% OVA for 10 minutes from day 18 to day 20. On day 21, lungs were excised to observe eosinophilic airway inflammation. All animal experiments were approved by the Animal Research Ethics Board of the Department of Allergy and Rheumatology, University of Tokyo.
###end p 17
###begin title 18
Measurement of airway responsiveness (AR)
###end title 18
###begin p 19
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 246 248 246 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 249 251 249 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 724 727 723 726 <sub xmlns:xlink="http://www.w3.org/1999/xlink">200</sub>
###xml 745 748 743 746 <sub xmlns:xlink="http://www.w3.org/1999/xlink">200</sub>
###xml 276 280 <span type="species:ncbi:10090">mice</span>
###xml 484 488 <span type="species:ncbi:10090">mice</span>
On day 22 (4 days after the transfer), AR to methacholine (Mch) was measured with the enhanced pause (Penh) system (Buxco, Troy, NY) as described previously [19,20]. In some experiments, AR was assessed by measurement of airway resistance (Raw) [21,22]. Briefly, anesthetized mice were tracheostomized and connected to a MiniVent ventilator (Hugo Sachs Elektronik, March, Germany), then ventilated with a tidal volume of 250 mul and a respiratory frequency of 120 breaths/minute. The mice were placed inside whole-body plethysmographs (Buxco) to measure Raw. Increasing doses of Mch were administered by ultraneblization for 3 minutes. The concentration of Mch that induced a 100% increase in Penh or Raw was expressed as PC200Mch (mug/ml) or PC200Mch Raw (mug/ml) as an indicator of AHR.
###end p 19
###begin title 20
Bronchoalveolar lavage (BAL) and histological examination
###end title 20
###begin p 21
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 88 90 88 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 690 692 683 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 894 896 887 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 897 899 890 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
Bronchoalveolar lavage fluid (BALF) analyses were performed as described previously [19,20]. The lungs were lavaged four times with SA (0.5 ml each), and approximately 1.6 ml was consistently recovered with gentle handling. The cell suspension was centrifuged at 1,500 rpm for 10 minutes at 4degreesC. The cells were resuspended into 1 ml of saline with 1% BSA, and the total cell numbers were counted with a hemocytometer. Cytospin samples were prepared by centrifuging the suspensions (200 mul) at 300 rpm for 10 minutes. To clearly distinguish eosinophils from the neutrophils, three different stains were applied: Diff-Quick stain, May-Grunwald-Giemsa stain, and Eosino (Hansel) stain [19]. On the basis of the findings with these stainings, cell differentials were counted with at least 300 leukocytes in each sample. Lung histological examinations were performed as described previously [19,20]. Serum immunoglobulin (Ig) E and BALF cytokine concentrations were measured using ELISA kits (Pharmingen, SanDiego, CA) according to the manufacturer's instructions. The lower limits of sensitivity for the ELISA were 78 ng/ml (IgE), 7.8 pg/ml (IL-4), 15.6 pg/ml (IL-5), and 31.2 pg/ml (interferon (IFN)-gamma), respectively.
###end p 21
###begin title 22
Fluorescence study and immunohistochemistry
###end title 22
###begin p 23
###xml 31 32 31 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 182 183 182 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 188 192 188 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 205 206 205 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 639 641 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1145 1146 1145 1146 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1147 1149 1147 1149 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 54 58 <span type="species:ncbi:10090">mice</span>
###xml 228 232 <span type="species:ncbi:10090">mice</span>
###xml 1250 1256 <span type="species:ncbi:9986">rabbit</span>
###xml 1474 1480 <span type="species:ncbi:9986">rabbit</span>
###xml 1486 1490 <span type="species:ncbi:9925">goat</span>
###xml 1862 1866 <span type="species:ncbi:9925">goat</span>
###xml 2069 2073 <span type="species:ncbi:9925">goat</span>
###xml 2079 2084 <span type="species:ncbi:10090">mouse</span>
On day 18, spleen cells (5 x 107) from OVA-sensitized mice were labeled with fluorescent dye (PKH67; Sigma), and then transferred into syngenic recipients. In another experiment, CD4+CD62Llow cells (4 x 106) from OVA-sensitized mice were positively selected as described in "depletion and positive selection study", and then labeled and transferred. On day 19, after perfusion with saline, lungs were excised. Five-micrometer sections were cut and observed by fluorescence microscopy (BX51; Olympus, Melville, NY). Immunohistochemistry was performed using Vectastain ABC kits (Vector Laboratories, Burlingame, CA) as described previously [23]. T cells were detected by staining for CD3 (cytoplasm, blue). Proliferation was assessed by staining for proliferating cell nuclear antigen (PCNA; nucleus, brown). Double-staining analysis of a single section was performed. Briefly, the tissue was deparaffinized and rehydrated with decreasing concentrations of ethyl alcohol. The slides were boiled in 0.05 M citric acid for 7 minutes. After cooling down to room temperature, endogenous peroxidase activity was blocked by incubating the slides in 3% H2O2 in methanol for 60 minutes. Next the slides were treated with blocking solution containing 5% normal rabbit serum, 2% casein, and 3% BSA for 45 minutes. Anti-CD3 Ab (5 mug/ml; Santa Cruz Biotechnology, Santa Cruz, CA) was applied to the tissue and incubated at 37degreesC for 30 minutes. After washing with PBS, biotinylated rabbit anti-goat IgG Ab was applied and incubated at 37degreesC for 30 minutes. After washing, avidin-biotin alkaline phosphatase complex was applied and incubated at 37degreesC for 30 minutes, followed by the addition of substrate solution. Color development was stopped by rinsing the slides in distilled water. Then, the slides were treated with blocking solution containing 5% normal goat serum, 2% casein, and 3% BSA for 45 minutes. Anti-PCNA Ab (2 mug/ml; Santa Cruz Biotechnology) was applied to the tissue and incubated at 37degreesC for 30 minutes. After washing with PBS, biotinylated goat anti-mouse IgG Ab was applied and incubated at 37degreesC for 30 minutes. After washing, avidin-biotin peroxidase complex was applied and incubated at 37degreesC for 30 minutes, followed by the addition of diaminobenzidine solution. Color development was stopped by rinsing the slides in distilled water. The slides were counterstained with neutral red. Positively immunostained cells were enumerated directly in 20 random high power fields (hpf; 40x objective).
###end p 23
###begin title 24
Depletion and positive selection study
###end title 24
###begin p 25
###xml 904 905 888 889 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 910 911 894 895 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 918 919 902 903 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 926 927 910 911 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 936 938 920 922 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1103 1104 1083 1084 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1109 1110 1089 1090 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1117 1118 1097 1098 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1125 1126 1105 1106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1132 1133 1112 1113 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1185 1187 1161 1163 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7 </sup>
###xml 1466 1468 1442 1444 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1477 1479 1453 1455 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1553 1555 1529 1531 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1569 1571 1545 1547 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1629 1631 1605 1607 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1641 1642 1617 1618 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 1652 1654 1628 1630 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1661 1662 1637 1638 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 1688 1689 1664 1665 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1694 1698 1670 1674 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 1713 1714 1689 1690 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1719 1724 1695 1700 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 1967 1968 1943 1944 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1973 1977 1949 1953 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 1984 1985 1960 1961 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 1993 1994 1969 1970 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1999 2004 1975 1980 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 2013 2014 1989 1990 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 59 63 <span type="species:ncbi:10090">mice</span>
###xml 500 504 <span type="species:ncbi:10090">mice</span>
###xml 670 675 <span type="species:ncbi:10090">mouse</span>
###xml 743 748 <span type="species:ncbi:10090">mouse</span>
###xml 1023 1028 <span type="species:ncbi:10090">mouse</span>
###xml 1262 1266 <span type="species:ncbi:10090">mice</span>
For depletion, on day 18, spleen cells from OVA-sensitized mice were incubated with biotinylated anti-CD4 monoclonal antibody (mAb; RM4-5; Pharmingen), anti-CD8 mAb (53-6.7; Pharmingen), anti-CD11b mAb (M1/70; Pharmingen), anti-CD11c mAb (HL3; Pharmingen), or anti-CD19 mAb (1D3; Pharmingen), and then incubated with streptavidin-microbeads (Miltenyi Biotech, Bergisch Gladbach, Germany). For depletion of invariant Valpha14 (iValpha14) natural killer T (NKT) cells, spleen cells from OVA-sensitized mice were incubated with alpha-galactosylceramide (alpha-GalCer; kindly provided by the Pharmaceutical Research Laboratory of Kirin Brewery Company, Gunma, Japan)-loaded mouse CD1d: Ig dimeric protein (Pharmingen) and then incubated with anti-mouse IgG1-microbeads (Miltenyi Biotech). Bead-bound cells were depleted using magnetic separation columns. Flow cytometry confirmed that greater than 98% of CD4+, CD8+, CD11b+, CD11c+, or CD19+ cells were removed from splenocytes, and 88% of cells that bound alpha-GalCer-loaded mouse CD1d dimer were removed (data not shown). Syngenic recipients received CD4+, CD8+, CD11b+, CD11c+, CD19+, or iValpha14 NKT cell-depleted splenocytes (5 x 107 each). For positive selection, on day 18, spleen cells from OVA-sensitized mice were incubated with anti-CD4 mAb-coated or anti-CD11c mAb-coated microbeads (Miltenyi Biotech). Bead-bound cells were then isolated using magnetic separation columns. The purities of the enriched CD4+ and CD11c+ cells were 95% and 85%, respectively (data not shown). Over 95% of the CD4+ cells were CD3+ T cells (data not shown). Syngenic recipients received CD4+ (1.25 x 107) or CD11c+ (1 x 106) cells. We prepared a CD4+CD62Llow subset or a CD4+CD62Lhigh subset using an anti-FITC multisort kit (Miltenyi Biotech), FITC anti-CD4 mAb (RM4-5; Pharmingen), and anti-CD62L mAb-coated microbeads (Miltenyi Biotech). The purities of each subset were 80% (data not shown). Syngenic recipients received CD4+CD62Llow (4 x 106) or CD4+CD62Lhigh (8.5 x 106) cells. AR was measured on day 22 (4 days after the transfer).
###end p 25
###begin title 26
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
In vitro OVA stimulation and polarization to Th1 or Th2 phenotype
###end title 26
###begin p 27
###xml 31 33 31 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 116 124 115 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 196 197 195 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 757 759 750 752 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 829 831 822 824 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 847 849 840 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 866 868 859 861 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
On day 18, spleen cells (5 x 106 cells/ml) from OVA-sensitized mice were incubated with OVA (200 mug/ml) for 4 days in vitro. On day 22, syngenic recipients received these stimulated cells (1 x 106). In some experiments, dead cells were removed from cultured splenocytes using Percoll (Pharmacia Biotech, Uppsala, Sweden) gradient centrifugation. For polarization to Th1 cells, recombinant IL-12 (10 ng/ml; Genzyme Techne, Minneapolis, MN) and anti-IL-4 Ab (0.1 mug/ml; Genzyme Techne) were added to the culture medium. For polarization to Th2 cells, recombinant IL-4 (100 ng/ml; Genzyme Techne) and anti-IL-12 Ab (0.25 mug/ml; Genzyme Techne) were added. Polarization was confirmed by measuring IL-4 and IFN-gamma in supernatant using ELISA. On day 22, CD4+ T cells were positively selected, and syngenic recipients received CD4+ Th1 cells or CD4+ Th2 cells (5 x 105 each). AR was measured on day 26 (4 days after the transfer).
###end p 27
###begin title 28
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
In vitro proliferation and cytokine assays
###end title 28
###begin p 29
###xml 23 25 23 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 37 38 37 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 43 48 43 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 64 65 64 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 70 74 70 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 91 93 91 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 229 231 229 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 139 143 <span type="species:ncbi:10090">mice</span>
Positively selected CD4+ T cells, CD4+CD62Lhigh T cells, and CD4+CD62Llow T cells (2.5 x 105 cells/well, respectively) from OVA-sensitized mice were cultured with freshly isolated mitomycin C (Sigma)-treated splenocytes (2.5 x 105 cells/well) in the presence or absence of OVA. After 48 hours, the proliferation was assessed by a cell proliferation ELISA bromodeoxyuridine (BrdU) kit (Roche Applied Science, Mannheim, Germany). After 72 hours, cytokine concentrations in the supernatants were measured using ELISA.
###end p 29
###begin title 30
Statistics
###end title 30
###begin p 31
###xml 159 161 157 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
Values are expressed as means +/- SEM. Statistical analysis was performed by one-way ANOVA followed by Fisher's least significant difference test or Student's t test. A p value < 0.05 was considered significant.
###end p 31
###begin title 32
Results
###end title 32
###begin title 33
###xml 62 66 <span type="species:ncbi:10090">mice</span>
Passive cell transfer of spleen cells from antigen-sensitized mice induces AHR
###end title 33
###begin p 34
###xml 24 26 24 26 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 105 108 105 108 <sub xmlns:xlink="http://www.w3.org/1999/xlink">200</sub>
###xml 207 209 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 511 513 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 621 622 612 613 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 627 630 618 621 <sub xmlns:xlink="http://www.w3.org/1999/xlink">200</sub>
###xml 819 820 807 808 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 851 853 836 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 1227 1229 1209 1211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 1261 1262 1240 1241 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 1295 1296 1271 1272 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 1327 1328 1300 1301 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 1576 1578 1549 1551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 1582 1585 1555 1558 <sub xmlns:xlink="http://www.w3.org/1999/xlink">200</sub>
###xml 1898 1899 1859 1860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 350 354 <span type="species:ncbi:10090">mice</span>
###xml 532 536 <span type="species:ncbi:10090">mice</span>
###xml 584 588 <span type="species:ncbi:10090">mice</span>
###xml 608 612 <span type="species:ncbi:10090">mice</span>
###xml 716 720 <span type="species:ncbi:10090">mice</span>
###xml 783 787 <span type="species:ncbi:10090">mice</span>
###xml 806 810 <span type="species:ncbi:10090">mice</span>
###xml 886 890 <span type="species:ncbi:10090">mice</span>
###xml 1068 1073 <span type="species:ncbi:10090">mouse</span>
###xml 1166 1170 <span type="species:ncbi:10090">mice</span>
###xml 1464 1468 <span type="species:ncbi:10090">mice</span>
###xml 1810 1814 <span type="species:ncbi:10090">mice</span>
As reported previously [19], immunization with OVA alone induced a significant increase in AR (OVA ip; PC200Mch; 3,870 +/- 518 mug/ml) as compared with saline injection (SAip; 5,725 +/- 1,009 mug/ml; Figure 1A). Injection with alum alone provoked a slight non-specific increase in AR, but it was not significant (data not shown). When OVA-sensitized mice received OVA inhalation challenges, then prominent infiltration of eosinophils was provoked and AR further increased (OVA/OVA; 2,564 +/- 343 mug/ml; Figure 1A). In the group of mice that received spleen cells from OVA-sensitized mice (defined as "TROVA-mice"; 5 x 107), PC200Mch was 4,191 +/- 203 mug/ml, which was significantly lower than that of the group of mice that received the same number of spleen cells from SA-treated mice (defined as "TRSA-mice"; 5 x 107; 6,357 +/- 835 mug/ml; Figure 1A). Transfer of spleen cells from mice that were injected with SA plus alum did not induce AHR (TRAlum; 6,596 +/- 697 mug/ml). Therefore, transfer of OVA-sensitized spleen cells reconstituted moderate AHR in a naive mouse to a similar degree of AHR induced by systemic sensitization with OVA antigen. In the TROVA-mice, AR increased in a cell-number dependent-manner (Figure 1B; 7,415 +/- 2,176 mug/ml (1 x 106), 6,343 +/- 1,392 mug/ml (5 x 106), 4,803 +/- 572 mug/ml (2 x 107), respectively). To confirm the reliability of the data obtained from the Penh system, we examined AR by measuring Raw with ventilated mice treated with the same immunization protocol. Similar results on AHR were obtained by measuring Raw (Figure 1C; PC200Mch Raw; SAip, 47,205 +/- 4,767 mug/ml, OVA ip, 20,668 +/- 1,562 mug/ml, TRSA, 46,702 +/- 6,653 mug/ml, TROVA, 22,450 +/- 9,535 mug/ml). So we used Penh system for the following experiments. In a time course study, the TROVA-mice revealed a significant increase in AR from 4 to 10 days after the transfer (Figure 2).
###end p 34
###begin p 35
###xml 0 103 0 103 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Passive cell transfer of spleen cells from OVA-sensitized mice induces airway hyperresponsiveness (AHR)</bold>
###xml 292 293 292 293 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 898 901 896 899 <sub xmlns:xlink="http://www.w3.org/1999/xlink">200</sub>
###xml 920 921 918 919 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 951 954 949 952 <sub xmlns:xlink="http://www.w3.org/1999/xlink">200</sub>
###xml 1126 1127 1124 1125 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 1166 1167 1164 1165 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 1175 1176 1173 1174 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 1184 1185 1182 1183 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 1196 1197 1194 1195 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 1270 1273 1268 1271 <sub xmlns:xlink="http://www.w3.org/1999/xlink">200</sub>
###xml 1292 1293 1290 1291 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 1407 1410 1405 1408 <sub xmlns:xlink="http://www.w3.org/1999/xlink">200</sub>
###xml 1433 1434 1431 1432 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 1464 1467 1462 1465 <sub xmlns:xlink="http://www.w3.org/1999/xlink">200</sub>
###xml 58 62 <span type="species:ncbi:10090">mice</span>
###xml 154 158 <span type="species:ncbi:10090">mice</span>
###xml 183 187 <span type="species:ncbi:10090">Mice</span>
###xml 326 330 <span type="species:ncbi:10090">mice</span>
###xml 332 336 <span type="species:ncbi:10090">TRSA</span>
###xml 354 358 <span type="species:ncbi:10090">mice</span>
###xml 394 398 <span type="species:ncbi:10090">mice</span>
###xml 572 576 <span type="species:ncbi:10090">mice</span>
###xml 651 655 <span type="species:ncbi:10090">mice</span>
###xml 741 745 <span type="species:ncbi:10090">mice</span>
###xml 855 859 <span type="species:ncbi:10090">mice</span>
###xml 908 912 <span type="species:ncbi:10090">TRSA</span>
###xml 1108 1112 <span type="species:ncbi:10090">mice</span>
###xml 1114 1118 <span type="species:ncbi:10090">TRSA</span>
###xml 1147 1151 <span type="species:ncbi:10090">mice</span>
###xml 1280 1284 <span type="species:ncbi:10090">TRSA</span>
###xml 1421 1425 <span type="species:ncbi:10090">TRSA</span>
Passive cell transfer of spleen cells from OVA-sensitized mice induces airway hyperresponsiveness (AHR). (A) Transfer of spleen cells from OVA-sensitized mice induces a moderate AHR. Mice were sensitized with OVA or SA on days 0 and 11. On day 18, recipients received the spleen cells (5 x 107) from SA (without alum)-treated mice (TRSA), OVA-sensitized mice (TROVA), or SA (with alum)-treated mice (TRAlum). Airway responsiveness (AR) to methacholine (Mch) was measured with Penh methods on day 22 (4 days after the transfer) as described in Methods. Some OVA-sensitized mice were inhaled with OVA from day 18 to day 20. AR was measured on day 18 in mice received that i.p SA injection (SAip) or OVA injection only (OVAip), or on day 21 in mice that received OVA-sensitization and -inhalation (OVA/OVA). Values are presented as means +/- SEM for 5 to 14 mice per group. * p < 0.05 compared with PC200Mch of TRSA (5 x 107). # p < 0.05 compared with PC200Mch of SAip. (B) AR to Mch increases in a transferred-cell-number-dependent manner (n = 5-14 per group). Recipients received spleen cells from SA-treated mice (TRSA; 5 x 107) or OVA-sensitized mice (TROVA; 1 x 106, 5 x 106, 2 x 107, or 5 x 107). AR was measured 4 days after the transfer. * p < 0.05 compared with PC200Mch of TRSA (5 x 107). (C) AR was assessed by measurement of airway resistance (Raw) (n = 6-12 per group). * p < 0.05 compared with PC200Mch Raw of TRSA (5 x 107). # p < 0.05 compared with PC200Mch Raw of SAip.
###end p 35
###begin p 36
###xml 0 37 0 37 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Change in AHR following cell transfer</bold>
###xml 79 80 79 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 321 324 321 324 <sub xmlns:xlink="http://www.w3.org/1999/xlink">200</sub>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
###xml 104 108 <span type="species:ncbi:10090">TRSA</span>
###xml 128 132 <span type="species:ncbi:10090">mice</span>
###xml 354 358 <span type="species:ncbi:10090">TRSA</span>
Change in AHR following cell transfer. Recipients received spleen cells (5 x 107) from SA-treated mice (TRSA) or OVA-sensitized mice (TROVA). AR was measured at the indicated time after the transfer (n = 8 per group). ## p < 0.01 compared with the baseline value (before the transfer) (ANOVA). * p < 0.05 compared with PC200Mch at the same time point of TRSA.
###end p 36
###begin title 37
Antigens that elicit Th2-type, but not Th1-type, immune response can induce AHR by cell transfer
###end title 37
###begin p 38
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 823 825 808 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 873 875 858 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 110 114 <span type="species:ncbi:10090">mice</span>
###xml 133 137 <span type="species:ncbi:10090">mice</span>
###xml 181 185 <span type="species:ncbi:10090">TRSA</span>
###xml 613 617 <span type="species:ncbi:10090">mice</span>
###xml 743 746 <span type="species:ncbi:31658">CFA</span>
###xml 877 881 <span type="species:ncbi:10090">TRSA</span>
###xml 945 948 <span type="species:ncbi:31658">CFA</span>
Next we confirmed other antigens than OVA could also induce AHR. Transfer of spleen cells from BSA-sensitized mice or KLH-sensitized mice also induced a significant AHR (Figure 3A; TRSA, 5,814 +/- 638 mug/ml, TROVA, 4,112 +/- 147 mug/ml, TRAlum, 6,224 +/- 680 mug/ml, TRBSA, 4,633 +/- 279 mug/ml, TRKLH, 4,123 +/- 280 mug/ml). In another experiment, we confirmed systemic sensitization alone with BSA or KLH induced AHR without eosinophilic inflammation (data not shown). We also confirmed that systemic sensitization with BSA or KLH increased serum IgE concentration (data not shown). When BSA or KLH sensitized mice received airway antigen challenge, eosinophilic airway inflammation was provoked (data not shown). On the other hand, use of CFA instead of alum as an adjuvant, which is known to elicit Th1-type immunity [24], did not induce transfer-mediated AHR (Figure 3B; TRSA, 5,814 +/- 638 mug/ml, TROVA/Alum, 4,112 +/- 147 mug/ml, TROVA/CFA, 5,224 +/- 74 mug/ml, TRCFA, 5,708 +/- 945 mug/ml). Therefore, it could be generally considered that antigens that elicit Th2-type immune response could induce a significant AHR by cell transfer.
###end p 38
###begin p 39
###xml 0 95 0 95 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Antigens that elicit Th2 type response, but not Th1 type response, induce transfer-mediated AHR</bold>
###xml 210 211 210 211 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 495 498 495 498 <sub xmlns:xlink="http://www.w3.org/1999/xlink">200</sub>
###xml 643 644 643 644 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 899 902 899 902 <sub xmlns:xlink="http://www.w3.org/1999/xlink">200</sub>
###xml 244 248 <span type="species:ncbi:10090">mice</span>
###xml 250 254 <span type="species:ncbi:10090">TRSA</span>
###xml 277 281 <span type="species:ncbi:10090">mice</span>
###xml 319 323 <span type="species:ncbi:10090">mice</span>
###xml 354 358 <span type="species:ncbi:10090">mice</span>
###xml 391 395 <span type="species:ncbi:10090">mice</span>
###xml 505 509 <span type="species:ncbi:10090">TRSA</span>
###xml 515 518 <span type="species:ncbi:31658">CFA</span>
###xml 662 666 <span type="species:ncbi:10090">mice</span>
###xml 668 672 <span type="species:ncbi:10090">TRSA</span>
###xml 707 711 <span type="species:ncbi:10090">mice</span>
###xml 741 744 <span type="species:ncbi:31658">CFA</span>
###xml 757 761 <span type="species:ncbi:10090">mice</span>
###xml 769 772 <span type="species:ncbi:31658">CFA</span>
###xml 783 786 <span type="species:ncbi:31658">CFA</span>
###xml 795 799 <span type="species:ncbi:10090">mice</span>
###xml 909 913 <span type="species:ncbi:10090">TRSA</span>
Antigens that elicit Th2 type response, but not Th1 type response, induce transfer-mediated AHR. (A) Antigens that elicit Th2 type response induce transfer-mediated AHR. Recipients received spleen cells (5 x 107) from SA (without alum)-treated mice (TRSA), from OVA-sensitized mice (TROVA), from SA (with alum)-treated mice (TRAlum), from BSA-sensitized mice (TRBSA), or from KLH-sensitized mice (TRKLH). AR was measured 4 days after the transfer (n = 4-9 per group). * p < 0.05 compared with PC200Mch of TRSA. (B) CFA, an adjuvant that elicits Th1 type response, does not induce transfer-mediated AHR. Recipients received spleen cells (5 x 107) from SA-treated mice (TRSA), from OVA (with alum)-sensitized mice (TROVA/Alum), from OVA (with CFA)-sensitized mice (TROVA/CFA), or from CFA-treated mice (TRCFA). AR was measured 4 days after the transfer (n = 4-9 per group). * p < 0.05 compared with PC200Mch of TRSA.
###end p 39
###begin title 40
The transfer-mediated AHR is provoked in an eosinophil-independent manner
###end title 40
###begin p 41
###xml 141 142 141 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 340 342 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 535 537 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 158 162 <span type="species:ncbi:10090">mice</span>
###xml 401 405 <span type="species:ncbi:10090">mice</span>
In the TROVA-mice, the number of total cell, macrophage, and lymphocyte in BALF slightly increased, whereas eosinophil number did not (Table 1). In the TROVA-mice, a slight infiltration of inflammatory cells into the peribronchial area was detected in some specimens. However, prominent infiltration of eosinophils was not detected (Figure 4A, left). In contrast, in the OVA-sensitized and challenged mice (OVA/OVA), prominent infiltration of eosinophils into the peribronchial interstitial area or bronchial wall was observed (Figure 4A, right). These results indicated that cell transfer induced AHR without prominent infiltration of eosinophils in the lung.
###end p 41
###begin p 42
BALF findings
###end p 42
###begin p 43
###xml 50 54 <span type="species:ncbi:10090">mice</span>
Values are presented as means +/- SEM for 5 to 14 mice per group.
###end p 43
###begin p 44
###xml 0 19 0 19 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Histologic findings</bold>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 107 111 <span type="species:ncbi:10090">mice</span>
###xml 129 133 <span type="species:ncbi:10090">mice</span>
###xml 290 294 <span type="species:ncbi:10090">mice</span>
###xml 518 522 <span type="species:ncbi:10090">mice</span>
###xml 798 802 <span type="species:ncbi:10090">mice</span>
###xml 850 854 <span type="species:ncbi:10090">mice</span>
###xml 872 876 <span type="species:ncbi:10090">mice</span>
###xml 920 924 <span type="species:ncbi:10090">mice</span>
###xml 926 930 <span type="species:ncbi:10090">TRSA</span>
###xml 1087 1091 <span type="species:ncbi:10090">mice</span>
###xml 1139 1143 <span type="species:ncbi:10090">mice</span>
###xml 1172 1176 <span type="species:ncbi:10090">mice</span>
###xml 1178 1182 <span type="species:ncbi:10090">TRSA</span>
###xml 1293 1297 <span type="species:ncbi:10090">mice</span>
###xml 1473 1477 <span type="species:ncbi:10090">mice</span>
Histologic findings. (A) H&E stain. Lung sections from mice that received spleen cells from OVA-sensitized mice (TROVA) and from mice that received OVA-sensitization and aerosol OVA-challenge (OVA/OVA) are shown. Scale bar, 200 mum. (B) Fluorescence study. Spleen cells from OVA-sensitized mice were labeled with fluorescent dye (PKH67), and then transferred into recipients. Five-micrometer sections of the lungs were observed by fluorescence microscopy 24 hours after the transfer (TROVA). A lung section from naive mice without transfer is shown (naive). Scale bar, 100 mum. (C) Double staining analysis of a single section by immunohistochemistry. T cells were detected by staining for CD3 (cytoplasm, blue). Proliferation was assessed by staining for PCNA (nucleus, brown). Lung sections from mice that received spleen cells from OVA-sensitized mice (TROVA) and from mice that received spleen cells from SA-treated mice (TRSA) are shown. Proliferating T cells were clearly detected (black arrow). Scale bar, 40 mum. (D) Histologic findings of colon (H&E stain). Colon sections from mice that received spleen cells from OVA-sensitized mice (TROVA) and from SA-treated mice (TRSA) are shown. Scale bar, 200 mum. (E)Transferred cells recruit into the colon. Spleen cells from OVA-sensitized mice were labeled, and transferred. Five-micrometer sections of the colons were observed by fluorescence microscopy 24 hours after the transfer (TROVA). A colon section from naive mice without transfer is shown (naive). Scale bar, 100 mum.
###end p 44
###begin title 45
Some transferred cells recruit into the lung, and some T cells proliferate without further airway antigen challenge
###end title 45
###begin p 46
###xml 249 251 249 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 595 597 593 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 705 707 701 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 36 40 <span type="species:ncbi:10090">mice</span>
###xml 110 114 <span type="species:ncbi:10090">mice</span>
###xml 277 281 <span type="species:ncbi:10090">mice</span>
###xml 565 569 <span type="species:ncbi:10090">mice</span>
###xml 626 630 <span type="species:ncbi:10090">TRSA</span>
###xml 631 635 <span type="species:ncbi:10090">mice</span>
We next analyzed lung sections from mice that received fluorescently labeled spleen cells from OVA-sensitized mice. The transferred cells were clearly detected in the lung 24 hours after the transfer, particularly in lung interstitial areas (Figure 4B, left). In contrast, the mice that had not received cell transfer did not show this finding (Figure 4B, right). Similar results were observed 3 days after the transfer (data not shown). Immunohistochemistry revealed that some T cells in the lung proliferated without further airway antigen challenge in the TROVA-mice (1.6 +/- 0.2/hpf; Figure 4C, left). In contrast, in the TRSA-mice, proliferation of T cells was less detected (0.5 +/- 0.1/hpf; Figure 4C, right).
###end p 46
###begin title 47
Transferred cells also distribute in other tissues and induce mild inflammation
###end title 47
###begin p 48
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4D</xref>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4D</xref>
###xml 434 436 434 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4E</xref>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 182 186 <span type="species:ncbi:10090">TRSA</span>
###xml 187 191 <span type="species:ncbi:10090">mice</span>
In the TROVA-mice, a slight infiltration of inflammatory cells was also detected in the mucosa of colon in some specimens (Figure 4D, left). In contrast, it was less detected in the TRSA-mice (Figure 4D, right). Similar results were obtained in tissues other than colon such as stomach and small intestine (data not shown). Fluorescence study revealed that transferred cells also distributed among other tissues such as colon (Figure 4E), stomach, liver, and spleen (data not shown). Therefore, transferred cells did not recruit specifically into the lung, but distributed throughout the body.
###end p 48
###begin title 49
Th2 cell-type cytokines, but not IgE, mediate transfer-induced AHR
###end title 49
###begin p 50
###xml 25 26 25 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 126 127 126 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 216 218 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 269 270 265 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 358 359 354 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 581 583 577 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 109 113 <span type="species:ncbi:10090">TRSA</span>
###xml 114 118 <span type="species:ncbi:10090">mice</span>
###xml 257 261 <span type="species:ncbi:10090">mice</span>
###xml 341 345 <span type="species:ncbi:10090">TRSA</span>
###xml 346 350 <span type="species:ncbi:10090">mice</span>
In the TROVA-mice (5 x 107), the concentrations of IL-4 and IL-5 were significantly higher than those of the TRSA-mice (5 x 107) (Figure 5A). The concentrations of IL-13 (data not shown) and IFN-gamma levels (Figure 5A) also slightly increased in the TROVA-mice (5 x 107), but these values were not significantly different from those of the TRSA-mice (5 x 107). Thus, Th2 cell-type cytokines increased in BALF, and their increases might play a pivotal role in the transfer-mediated AHR. We also measured serum IgE concentration. No significant increase in IgE was detected (Figure 5B), suggesting that IgE did not mediate transfer-induced AHR.
###end p 50
###begin p 51
###xml 0 46 0 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Concentrations of BALF cytokines and serum IgE</bold>
###xml 320 321 316 317 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 308 312 <span type="species:ncbi:10090">TRSA</span>
Concentrations of BALF cytokines and serum IgE. (A) BALF cytokine concentrations. Four days after the transfer, BAL was performed and then the centrifuged supernatant was assayed for IL-4, IL-5, and IFN-gamma concentrations by ELISA, respectively (n = 5-14 per group). * p < 0.05 compared with the values of TRSA (5 x 107). (B) Serum IgE concentrations (n = 5-14 per group). *** p < 0.001 compared with the values of SAip.
###end p 51
###begin title 52
IL-4 plays an important role in transfer-mediated AHR
###end title 52
###begin p 53
###xml 24 26 24 26 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 291 292 291 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 360 363 354 357 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 397 400 388 391 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 238 242 <span type="species:ncbi:10090">mice</span>
###xml 294 298 <span type="species:ncbi:10090">TRSA</span>
###xml 351 355 <span type="species:ncbi:10090">TRSA</span>
As reported previously [19], IL-4 played a pivotal role in AHR that induced by antigen sensitization alone. So, we next examined the role of IL-4 in this transfer-mediated AHR. Transfer of spleen cells from OVA-sensitized, IL-4-deficient mice failed to induce the development of AHR (Figure 6; TRSA, 6,554 +/- 758 mug/ml, TROVA, 4,209 +/- 287 mug/ml, TRSA/IL-4-/-, 6,723 +/- 765 mug/ml, TROVA/IL-4-/-, 6,593 +/- 698 mug/ml) and an increase in BALF IL-4 concentration was not detected (data not shown). These results suggested that IL-4 production by OVA-sensitized spleen cells played an important role in the induction of transfer-mediated AHR.
###end p 53
###begin p 54
###xml 0 53 0 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink">IL-4 plays an important role in transfer-mediated AHR</bold>
###xml 95 96 95 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 227 230 227 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 287 290 287 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 383 386 383 386 <sub xmlns:xlink="http://www.w3.org/1999/xlink">200</sub>
###xml 426 429 426 429 <sub xmlns:xlink="http://www.w3.org/1999/xlink">200</sub>
###xml 124 128 <span type="species:ncbi:10090">mice</span>
###xml 130 134 <span type="species:ncbi:10090">TRSA</span>
###xml 167 171 <span type="species:ncbi:10090">mice</span>
###xml 212 216 <span type="species:ncbi:10090">mice</span>
###xml 218 222 <span type="species:ncbi:10090">TRSA</span>
###xml 271 275 <span type="species:ncbi:10090">mice</span>
###xml 393 397 <span type="species:ncbi:10090">TRSA</span>
IL-4 plays an important role in transfer-mediated AHR. Recipients received spleen cells (5 x 107) from SA-treated wild-type mice (TRSA), from OVA-sensitized wild-type mice (TROVA), from SA-treated IL-4-deficient mice (TRSA/IL-4-/-), or from OVA-sensitized IL-4-deficient mice (TROVA/IL-4-/-). AR was measured 4 days after the transfer (n = 6-8 per group). * p < 0.05 compared with PC200Mch of TRSA. # p < 0.05 compared with PC200Mch of TROVA.
###end p 54
###begin title 55
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
In vitro OVA stimulation potentiates the intensity of transfer-mediated AHR
###end title 55
###begin p 56
###xml 76 85 76 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
###xml 224 225 221 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 263 264 257 258 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 338 339 329 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 458 460 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B</xref>
###xml 183 187 <span type="species:ncbi:10090">TRSA</span>
###xml 317 321 <span type="species:ncbi:10090">mice</span>
In another experiment, OVA-sensitized spleen cells were stimulated with OVA in vitro and then transferred. This treatment increased the intensity of transfer-mediated AHR (Figure 7A; TRSA, 6,556 +/- 703 mug/ml, TROVA (1 x 106), 6,848 +/- 997 mug/ml, TROVA (5 x 107), 4,607 +/- 205 mug/ml, stimulated cell-transferred mice (TRSTIM) (1 x 106), 3,654 +/- 459 mug/ml). BALF cytokine concentrations of the recipients were also increased by this treatment (Figure 7B). This result indicated that stronger antigen stimulus induced stronger immune response, which resulted in the induction of higher AHR.
###end p 56
###begin p 57
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
###xml 0 73 0 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>In vitro </italic>OVA stimulation increases the intensity of transfer-mediated AHR</bold>
###xml 89 98 89 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 171 173 171 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 256 264 255 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 360 361 359 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 455 458 454 457 <sub xmlns:xlink="http://www.w3.org/1999/xlink">200</sub>
###xml 477 478 476 477 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 508 511 507 510 <sub xmlns:xlink="http://www.w3.org/1999/xlink">200</sub>
###xml 531 532 530 531 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 810 811 805 806 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 866 867 861 862 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 203 207 <span type="species:ncbi:10090">mice</span>
###xml 465 469 <span type="species:ncbi:10090">TRSA</span>
###xml 798 802 <span type="species:ncbi:10090">TRSA</span>
In vitro OVA stimulation increases the intensity of transfer-mediated AHR. (A) Effect of in vitro OVA stimulation on transfer-mediated AHR. On day 18, spleen cells (5 x 106 cells/ml) from OVA-sensitized mice were incubated with OVA (200 mug/ml) for 4 days in vitro. On day 22, recipients received these stimulated cells by intravenous injection (TRSTIM: 1 x 106). AR was measured 4 days after the transfer (n = 5-10 per group). * p < 0.05 compared with PC200Mch of TRSA (5 x 107). # p < 0.05 compared with PC200Mch of TROVA (1 x 106). (B) BALF cytokine concentrations. Four days after the transfer, BAL was performed and then the centrifuged supernatant was assayed for IL-4, IL-5, and IFN-gamma concentrations using ELISA, respectively (n = 5-10 per group). * p < 0.05 compared with the values of TRSA (5 x 107). # p < 0.05 compared with the values of TROVA (1 x 106).
###end p 57
###begin title 58
###xml 3 5 3 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
CD4+ Th2 cells induce AHR
###end title 58
###begin p 59
###xml 122 124 122 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 214 216 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8A</xref>
###xml 617 619 589 591 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 628 630 600 602 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 711 713 683 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 744 746 716 718 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 840 842 812 814 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 886 888 858 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8B</xref>
###xml 1286 1288 1246 1248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8C</xref>
###xml 1302 1303 1262 1263 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1346 1348 1306 1308 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1392 1394 1352 1354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8D</xref>
###xml 161 165 <span type="species:ncbi:10090">mice</span>
###xml 218 222 <span type="species:ncbi:10090">TRSA</span>
###xml 861 865 <span type="species:ncbi:10090">mice</span>
###xml 890 894 <span type="species:ncbi:10090">TRSA</span>
To determine which cells are most important for this AHR induction, we carried out a cell depletion study. Transfer of CD4+ cell-depleted splenocytes into naive mice failed to induce the development of AHR (Figure 8A; TRSA, 6,240 +/- 577 mug/ml, TROVA, 3,858 +/- 325 mug/ml, CD4 (-), 5,695 +/- 543 mug/ml, CD8 (-), 3,738 +/- 368 mug/ml, CD11b (-), 3,528 +/- 327 mug/ml, CD11c (-), 4,077 +/- 206 mug/ml, CD19 (-), 3,694 +/- 434 mug/ml, iValpha14 NKT (-), 3,497 +/- 345 mug/ml) or failed to increase BALF cytokine concentrations (data not shown). We next carried out positive selection. We determined the numbers of CD4+ and CD11c+ spleen cells to be transferred based on the physiologic ratio of these cells (CD4+ spleen cells were 25% and CD11c+ spleen cells were 2% of total spleen cells, respectively). Transfer of positively selected CD4+ T cells into naive mice induced AHR (Figure 8B; TRSA, 7,061 +/- 831 mug/ml, TROVA, 4,381 +/- 102 mug/ml, CD4, 4,526 +/- 560 mug/ml, CD11c, 5,637 +/- 1,040 mug/ml) and an elevation of BALF cytokine levels (data not shown), which were consistent with the results of depletion study. Next, we elucidated which of the two CD4-mediated response play a major role for AHR induction. Spleen cells were polarized to either Th1 or Th2 phenotype (Figure 8C) and each CD4+population was transferred. Transfer of CD4+ Th2, but not Th1, cells induced AHR (Figure 8D; Th1, 5,732 +/- 508 mug/ml, Th2, 4,384 +/- 151 mug/ml).
###end p 59
###begin p 60
###xml 3 5 3 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 0 34 0 34 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CD4<sup>+ </sup>Th2 cells directly induce AHR</bold>
###xml 97 98 97 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 189 190 189 190 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 217 219 217 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 248 250 248 250 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 281 283 281 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 313 315 313 315 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 435 437 427 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7 </sup>
###xml 549 552 541 544 <sub xmlns:xlink="http://www.w3.org/1999/xlink">200</sub>
###xml 583 585 575 577 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 593 595 585 587 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 709 710 701 702 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 745 746 737 738 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 752 754 744 746 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 769 770 761 762 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 781 783 773 775 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 797 798 789 790 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 929 932 921 924 <sub xmlns:xlink="http://www.w3.org/1999/xlink">200</sub>
###xml 1018 1020 1010 1012 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 1103 1111 1094 1102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1309 1311 1300 1302 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1541 1543 1527 1529 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1602 1604 1588 1590 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1699 1701 1685 1687 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1725 1726 1711 1712 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 1819 1822 1805 1808 <sub xmlns:xlink="http://www.w3.org/1999/xlink">200</sub>
###xml 1851 1853 1837 1839 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 122 126 <span type="species:ncbi:10090">TRSA</span>
###xml 146 150 <span type="species:ncbi:10090">mice</span>
###xml 423 427 <span type="species:ncbi:10090">mice</span>
###xml 691 695 <span type="species:ncbi:10090">mice</span>
###xml 697 701 <span type="species:ncbi:10090">TRSA</span>
###xml 833 837 <span type="species:ncbi:10090">mice</span>
###xml 939 943 <span type="species:ncbi:10090">TRSA</span>
###xml 1050 1054 <span type="species:ncbi:10090">mice</span>
###xml 1829 1833 <span type="species:ncbi:10090">mice</span>
CD4+ Th2 cells directly induce AHR. (A) Depletion study. Recipients received spleen cells (5 x 107) from SA-treated mice (TRSA) or OVA-sensitized mice (TROVA). Other recipients received CD4+cell-depleted (CD4(-)), CD8+ cell-depleted (CD8(-)), CD11b+ cell-depleted (CD11b(-)), CD11c+ cell-depleted (CD11c(-)), CD19+ cell-depleted (CD19(-)), or iValpha14 NKT cell-depleted (iValpha14 NKT(-)) spleen cells from OVA-sensitized mice (5 x 107 each), respectively. AR was measured 4 days after the transfer (n = 6-10 per group). * p < 0.05 compared with PC200Mch of TROVA. (B) Effect of CD4+ or CD11c+ cells on transfer-mediated AHR. Recipients received unfractionated spleen cells from SA-treated mice (TRSA; 5 x 107), or unfractionated (TROVA; 5 x 107), CD4+ (CD4; 1.25 x 107), or CD11c+ (CD11c; 1 x 106) spleen cells from OVA-sensitized mice. AR was measured 4 days after the transfer (n = 5-8 per group). * p < 0.05 compared with PC200Mch of TRSA. (C) Polarization to Th1 or Th2 phenotype. On day 18, spleen cells (5 x 106 cells/ml) from OVA-sensitized mice were incubated with OVA (200 mug/ml) for 4 days in vitro. For polarization toward Th1 cells, IL-12 and anti-IL-4 Ab were added to the culture medium. For polarization toward Th2 cells, IL-4 and anti-IL-12 Ab were added. On day 22, positively selected CD4+ T cells were cultured with freshly isolated mitomycin C-treated splenocytes and OVA (200 mug/ml). After 96 hours, IL-4 and IFN-gamma concentrations in the supernatants were assayed. *** p < 0.001 compared with the value of the CD4+ Th1 cells. ### p < 0.001 compared with the value of the CD4+ Th2 cells. (D) Effect of Th1 or Th2 phenotype on transfer-mediated AHR. Recipients received CD4+ Th1 or Th2 cells (5 x 105). AR was measured 4 days after the transfer (n = 5-6 per group). * p < 0.05 compared with PC200Mch of mice that received CD4+ Th1 cells.
###end p 60
###begin title 61
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 9 13 9 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
CD4+CD62Llow memory/effector T cells play an essential role in the transfer-induced AHR
###end title 61
###begin p 62
###xml 65 67 65 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 393 394 393 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 399 404 399 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 419 420 419 420 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 425 429 425 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 504 513 504 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 529 533 529 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 638 643 638 643 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 666 668 666 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9A</xref>
###xml 673 675 673 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9B</xref>
###xml 697 701 697 701 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 935 940 935 940 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 949 953 949 953 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 1034 1039 1034 1039 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 1063 1067 1063 1067 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 1096 1098 1096 1098 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1143 1147 1143 1147 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 1188 1193 1188 1193 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 1221 1223 1221 1223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9C</xref>
###xml 1393 1395 1384 1386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9D</xref>
###xml 1399 1402 1390 1393 <sub xmlns:xlink="http://www.w3.org/1999/xlink">200</sub>
###xml 1553 1554 1535 1536 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1559 1563 1541 1545 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 1610 1612 1592 1594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9E</xref>
###xml 1660 1664 1642 1646 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 1760 1762 1742 1744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9F</xref>
###xml 1806 1807 1788 1789 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1812 1816 1794 1798 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 744 748 <span type="species:ncbi:10090">mice</span>
###xml 1632 1636 <span type="species:ncbi:10090">mice</span>
The results obtained so far indicated that antigen-stimulated CD4+ Th2 cells reached the lung and proliferated there, then produced Th2-type cytokine, which resulted in the direct induction of AHR. They also indicated that antigen-pulsed memory/effector T cell phenotype might play an important role in the transfer-mediated AHR induction. So, finally we examined their role in our system. CD4+CD62Lhigh T cells and CD4+CD62Llow T cells were prepared by Ab-coated microbeads and column separation. In an in vitro study, the CD62Llow memory/effector subset proliferated and produced Th2-type cytokines in response to OVA, whereas the CD62Lhigh subset did not (Figure 9A and 9B). Moreover, the CD62Llow memory/effector subset from OVA-sensitized mice produced Th2-type cytokines even without further antigen stimulation, although the values were low (data not shown). Then, we performed transfer study. We determined the numbers of CD62Lhigh and CD62Llow cells to be transferred based on the physiologic ratio of these phenotypes (CD62Lhigh cells were 68% and CD62Llow cells were 32% of splenic CD4+ T cells, respectively). Transfer of the CD62Llow memory/effector subset, but not the CD62Lhigh subset, induced AHR (Figure 9C; CD4, 3,968 +/- 258 mug/ml, CD62Lhi, 6,549 +/- 645 mug/ml, CD62Llo, 3,824 +/- 420 mug/ml). When we evaluated AHR by measuring Raw, similar results were obtained (Figure 9D; PC200Mch Raw; CD4, 23,840 +/- 3,350 mug/ml, CD62Lhi, 41,146 +/- 6,451 mug/ml, CD62Llo, 22,146 +/- 6,150 mug/ml). We also confirmed that some transferred CD4+CD62Llow cells actually recruited into the lung (Figure 9E). Moreover, in the mice that received the CD62Llow subset, some T cells in the lung proliferated there without further antigen stimulation (Figure 9F). These results strongly indicated that CD4+CD62Llow memory/effector T cells were essential for this transfer-mediated, antigen-induced AHR.
###end p 62
###begin p 63
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 9 13 9 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 0 106 0 106 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CD4<sup>+</sup>CD62L<sup>low </sup>memory/effector subset produces Th2-type cytokines and directly induces transfer-mediated AHR</bold>
###xml 120 121 120 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 126 130 126 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 238 240 238 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 258 259 258 259 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 264 269 264 269 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 294 295 294 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 300 304 300 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 679 680 679 680 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 685 689 685 689 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 884 885 884 885 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 890 895 890 895 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 917 918 917 918 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 923 927 923 927 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 986 988 986 988 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1003 1004 1003 1004 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 1010 1011 1010 1011 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1016 1021 1016 1021 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 1039 1040 1039 1040 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 1049 1050 1049 1050 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1055 1059 1055 1059 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 1075 1076 1075 1076 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 1237 1240 1237 1240 <sub xmlns:xlink="http://www.w3.org/1999/xlink">200</sub>
###xml 1269 1270 1269 1270 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1275 1280 1275 1280 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 1379 1382 1379 1382 <sub xmlns:xlink="http://www.w3.org/1999/xlink">200</sub>
###xml 1415 1416 1415 1416 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1421 1426 1421 1426 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 1461 1462 1461 1462 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1467 1471 1467 1471 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 1509 1510 1509 1510 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 1960 1961 1959 1960 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1966 1970 1965 1969 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 1992 1993 1991 1992 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 342 346 <span type="species:ncbi:10090">mice</span>
###xml 717 721 <span type="species:ncbi:10090">mice</span>
###xml 1104 1108 <span type="species:ncbi:10090">mice</span>
###xml 1247 1251 <span type="species:ncbi:10090">mice</span>
###xml 1393 1397 <span type="species:ncbi:10090">mice</span>
###xml 1497 1501 <span type="species:ncbi:10090">mice</span>
###xml 1923 1927 <span type="species:ncbi:10090">mice</span>
CD4+CD62Llow memory/effector subset produces Th2-type cytokines and directly induces transfer-mediated AHR. (A and B)CD4+CD62Llow memory/effector subset proliferates and produces Th2-type cytokines with antigen stimulation. On day 18, CD4+ T cells (CD4), CD4+CD62Lhigh T cells (CD62Lhi), or CD4+CD62Llow T cells (CD62Llo) from OVA-sensitized mice were positively selected by magnetic cell sorting as described in Methods. Then, these cells were cultured with freshly isolated mitomycin C-treated splenocytes in the presence of OVA. After 48 hours, the proliferation was assessed by BrdU incorporation using ELISA (A). The maximum proliferation observed in response to OVA for CD4+CD62Llow T cells from OVA-sensitized mice was set as control (100%). After 72 hours, Th2-type cytokine levels in the supernatants were assayed using ELISA (B). *** p < 0.001 compared with the value of CD4+CD62Lhigh T cells. (C and D) CD4+CD62Llow memory/effector T cells induce AHR. Recipients received CD4+ (CD4; 1.25 x 107), CD4+CD62Lhigh (CD62Lhi; 8.5 x 106), or CD4+CD62Llow (CD62Llo; 4 x 106) cells from OVA-sensitized mice. AR was measured 4 days after the transfer. (C) AR was measured by Penh methods (n = 5-6 per group). * p < 0.05 compared with PC200Mch of mice that received CD4+CD62Lhigh T cells. (D) AR was assessed by measurement of Raw (n = 6-8 per group). * p < 0.05 compared with PC200Mch Raw of mice that received CD4+CD62Lhigh T cells. (E)Fluorescence study. CD4+CD62Llow cells from OVA-sensitized mice (4 x 106) were labeled with fluorescent dye, and then transferred into recipients. Five-micrometer sections of the lungs were observed by fluorescence microscopy 24 hours after the transfer (CD62Llo). Scale bar, 100 mum. (E) Double staining analysis by immunohistochemistry. T cells were detected by staining for CD3 (cytoplasm, blue). Proliferation was assessed by staining for PCNA (nucleus, brown). Lung sections from mice that received OVA-sensitized CD4+CD62Llow cells (CD62Llo; 4 x 106) are shown. Proliferating T cells were clearly detected (black arrow). Scale bar, 40 mum.
###end p 63
###begin title 64
Discussion
###end title 64
###begin p 65
###xml 175 176 175 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 181 185 181 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 107 111 <span type="species:ncbi:10090">mice</span>
In the current study, we demonstrated that transfer of antigen-induced cellular immune response into naive mice reconstituted AHR in an antigen free setting. We found that CD4+CD62Llow Th2 cells play an essential role in this process. Our results strongly suggest that in sensitized individuals, memory/effector T cells could reach the lung tissue and locally act on the airways, thus would directly induce and maintain basal AHR independently of eosinophils, although the intensity could be moderate.
###end p 65
###begin p 66
###xml 58 59 58 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 236 237 236 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 238 239 238 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 240 241 240 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 364 366 364 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 389 391 389 391 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 445 447 445 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 448 450 448 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 451 453 451 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 503 505 503 505 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 879 881 879 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1058 1059 1058 1059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1068 1069 1068 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 1078 1080 1078 1080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 1092 1093 1092 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1370 1372 1370 1372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 977 981 <span type="species:ncbi:10090">mice</span>
###xml 1017 1021 <span type="species:ncbi:10090">mice</span>
###xml 1186 1192 <span type="species:ncbi:9606">humans</span>
###xml 1227 1235 <span type="species:ncbi:9606">patients</span>
###xml 1477 1483 <span type="species:ncbi:9606">humans</span>
AHR is one of the most characteristic features of asthma [1]. However, the precise mechanism for its induction has not been fully clarified. It is considered that eosinophilic airway inflammation is closely linked to the AHR induction [1,4,5]. However, a causal link between eosinophilic airway inflammation and AHR has not been established. On the other hand, CD4+ T cells, especially CD4+ Th2 cells, are also involved in the induction of AHR [11,13-18]. However, the significance of eosinophils or CD4+ T cells on the AHR induction has been clarified only in the effector phase, under the condition of airway antigen challenge. Therefore, the role of these cells in the AHR induction has not been evaluated in an antigen free setting. We previously reported that systemic antigen sensitization alone directly induces AHR before development of eosinophilic airway inflammation [19]. In addition, in the current study, transfer of spleen cells obtained from antigen-sensitized mice induced a significant AHR in naive mice without airway eosinophilia (Figure 1, Figure 3, Figure 4A, and Table 1). These results indicate that antigen-sensitized spleen cells could directly induce AHR. In humans, we previously reported that some patients with atopic dermatitis who are highly sensitized to mite antigen have a moderate AHR regardless of the lack of any history of asthma [25]. This would support the speculation that sensitization to an antigen could directly induce AHR also in humans.
###end p 66
###begin p 67
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 671 673 671 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 674 676 674 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 773 775 773 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 776 778 776 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 939 941 939 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 946 948 946 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9D</xref>
###xml 139 143 <span type="species:ncbi:10090">mice</span>
###xml 214 218 <span type="species:ncbi:10090">mice</span>
###xml 472 476 <span type="species:ncbi:10090">mice</span>
###xml 665 669 <span type="species:ncbi:10090">mice</span>
###xml 891 895 <span type="species:ncbi:10090">mice</span>
We measured AR mainly by Penh system throughout the current study. Penh system has been widely used for measurement of AR to Mch in BALB/c mice [19,20,26]. Measuring Penh is superior to measuring Raw of ventilated mice in terms of its conciseness and non-invasiveness. In addition, sampling bias caused by maneuver in Penh system seemed to be lower than that in invasive ventilator system. Based on these advantages of Penh system, we could measure AR of large numbers of mice simultaneously with a good reproducibility. However, the accuracy of Penh as an indicator of AR has been recently criticized because Penh does not correlate with Raw especially in C57BL/6 mice [27-29]. Measuring Penh is more frequently affected by the heat and humidification than measuring Raw [30,31]. Considering these experimental and theoretical problems, we also examined AR by measuring Raw with ventilated mice in the most important experiments (Figures 1C and 9D). We confirmed that similar results were obtained by the two systems. Therefore, we considered that the data obtained from the Penh system in the current study were, to a certain extent, reliable.
###end p 67
###begin p 68
###xml 266 268 266 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 273 275 273 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 290 295 290 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 386 388 386 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 397 402 397 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 512 514 512 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 796 798 796 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4D</xref>
###xml 803 805 803 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4E</xref>
###xml 391 396 <span type="species:ncbi:33453">Julia</span>
Next we studied the mechanism of the cell transfer-induced AHR. The fluorescence study and double staining demonstrated that these transferred cells reached the lung and some T cells actually proliferated in the lung without further airway antigen challenge (Figure 4B and 4C). Byersdorfer et al. reported that some transferred Th1 cells migrate in the airway before antigen challenge [32]. Julia et al. reported that antigen sensitization alone distributes antigen-specific T cells in the BALF and in the lung [33]. These reports support the present findings. Therefore, some antigen specific T cells could have reached the lung in an antigen free setting. On the other hand, transferred cells reached the tissues other than lung such as colon, which induced a slight inflammation there (Figure 4D and 4E). These results suggested that antigen sensitization or transfer of antigen-sensitized spleen cells would distribute antigen-specific T cells among tissues, and thus could induce some immure response there even without local antigen challenge.
###end p 68
###begin p 69
###xml 51 53 51 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 74 76 74 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 94 96 94 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8D</xref>
###xml 119 121 119 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 269 270 269 270 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 275 279 275 279 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 372 373 372 373 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 378 383 378 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 432 433 428 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 438 439 434 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9</xref>
###xml 490 492 486 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 552 554 548 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 568 572 564 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 653 657 649 653 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 778 780 774 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 781 783 777 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 839 841 835 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 927 929 923 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 948 952 944 948 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 1022 1024 1018 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 1025 1027 1021 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1060 1064 1056 1060 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 1151 1156 1147 1152 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 1179 1181 1175 1177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9A</xref>
###xml 1186 1188 1182 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9B</xref>
###xml 1218 1222 1214 1218 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 1317 1319 1313 1315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9E</xref>
###xml 1324 1326 1320 1322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9F</xref>
###xml 1691 1693 1687 1689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1738 1740 1734 1736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 1745 1747 1741 1743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
The result of BALF cytokine concentrations (Figure 5A) and transfer of CD4+ Th2 cells (Figure 8D) demonstrated that CD4+ Th2 cells played an essential role in the induction of the AHR. In addition, results from positive and negative selection studies clarified that CD4+CD62Llow T cells were essential for transfer-induced AHR induction, while other phenotypes such as CD4+CD62Lhigh T cells or iValpha14 NKT cells were not (Figures 8 and 9). There are two distinct populations of memory CD4+ T cells, which are distinguished by the expression of CCR7 [34]. One is CCR7high central memory T cells which home preferentially to lymph nodes, another is CCR7low effector memory cells which traffic more efficiently to non-lymphoid tissues and acquire effector function more rapidly [34,35]. Central memory T cells express high levels of CD62L [34]. In contrast, effector memory T cells express CD62L to a lower and variable extent [34]. Therefore, CD62Llow memory T cells are thought to be a subset of effector memory T cells [34,36]. We demonstrated that the CD62Llow subset proliferated and produced Th2-type cytokines in response to OVA, while the CD62Lhigh subset did not (Figure 9A and 9B). Moreover, transferred CD62Llow subset recruited into the lung, and proliferated there without local antigen challenge (Figure 9E and 9F). Therefore, in our system, some antigen specific T cells could have acquired a memory/effector phenotype (effector memory T cells), reached the lung, proliferated and produced cytokines, then finally induced AHR in an antigen free setting. Furthermore, local antigen stimuli would further accelerate immune response and thus airway eosinophilia would be induced [37], which could further increase AHR (Figures 1A and 4A).
###end p 69
###begin p 70
###xml 98 103 98 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 178 183 178 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 220 222 220 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
So far, whether immunocompetent cells would modify intrinsic AHR has remained unclear. De Sanctis et al. reported that T lymphocytes mediate intrinsic AHR [38]. However, Hadeiba et al. later reported that transfer of CD4+ T cells that are not stimulated with antigen does not alter the intrinsic AHR [39]. The latter finding is strongly supported by the present findings that antigen-stimulated cells mediated AHR induction, while cells that had not encountered antigen did not.
###end p 70
###begin p 71
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B</xref>
###xml 162 167 162 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 183 192 183 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 375 377 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 378 380 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 427 436 427 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 589 598 589 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 740 741 740 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 513 517 <span type="species:ncbi:10090">mice</span>
In vitro OVA stimulation of OVA sensitized spleen cells enhanced transfer activity to induce AHR (Figure 7A) and cytokine concentration in BALF (Figure 7B). Wise et al. reported that in vitro OVA stimulation enhances transfer activity to provoke eosinophilic airway inflammation [37]. We needed larger numbers of OVA-sensitized spleen cells to induce AHR than other studies [17,18], because we did not stimulate cells with OVA in vitro before transfer in most part of this study. Spleen cells from OVA-sensitized mice produced greater amount of cytokines upon further stimulation with OVA in vitro (data not shown). Therefore, the more Th2-type cytokine was produced by transferred cells, the greater the intensity of AHR increased (Figure 7).
###end p 71
###begin p 72
###xml 31 33 31 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 251 253 251 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 254 256 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 274 276 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 419 420 419 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 590 591 590 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 710 712 706 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 713 715 709 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 844 846 840 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 983 985 979 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 986 988 982 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 1013 1015 1009 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1103 1105 1099 1101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 1106 1108 1102 1104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 1175 1177 1171 1173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1178 1180 1174 1176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 1287 1289 1279 1281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8A</xref>
###xml 558 562 <span type="species:ncbi:10090">mice</span>
###xml 1169 1173 <span type="species:ncbi:10090">mice</span>
Among cytokines produced by CD4+ Th2 cells, which is most important for developing of AHR has not been fully clarified. IL-13 is a candidate for developing AHR independently of eosinophilic inflammation [12]. On the other hand, some previous studies [10,40] including ours [19] showed that IL-4 also plays an important role. In the current study, IL-4 and IL-5 concentrations in BALF increased by cell transfer (Figure 5), while IL-13 did not increase significantly (data not shown). Moreover, transfer of spleen cells from antigen-sensitized IL-4-deficient mice did not induce AHR (Figure 6). So in the present experimental system, IL-4 would play a major role. Airway smooth muscle cells express IL-4Ralpha [41,42]. We speculate that one of the mechanisms of AHR induction by cell transfer could be a direct influence on smooth muscle cells [43]. The relationship between Th2 cytokine and smooth muscle cell should be further elucidated. NKT cells are another cell source of IL-4 [44-47] and IL-13 productions [44], and would influence the subsequent adaptive immune response and T cell polarization [45,47]. The development of AHR is abrogated in NKT-cell deficient mice [44,46]. However, in the current study, iValpha14 NKT cells did not influence this transfer-mediated AHR (Figure 8A). This indicates that although NKT cells might play some important role in a certain phase of sensitization, once conventional T cells are activated and gain effector function, iValpha14 NKT cells would have little contribution to the induction of AHR.
###end p 72
###begin title 73
Conclusion
###end title 73
###begin p 74
###xml 99 101 99 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
In conclusion, the current study clarified the significance of antigen-specific memory/effector CD4+ T cell-mediated Th2-type immune response as an essential factor to induce basal AHR in an antigen independent setting. It would also propose that suppression of antigen-specific immune response itself should be a critical target for controlling allergic asthma.
###end p 74
###begin title 75
Competing interests
###end title 75
###begin p 76
The author(s) declare that they have no competing interests.
###end p 76
###begin title 77
Authors' contributions
###end title 77
###begin p 78
KN and MD carried out animal experiments and preparation of the manuscript. KO, YT, AS and RT carried out animal experiments. YK and KN assisted with positive/negative cell selections. KY participated in the direction of the study. All authors read and approved the final manuscript.
###end p 78
###begin title 79
Acknowledgements
###end title 79
###begin p 80
We thank I. Makino, E. Kasukawa, A. Tobimatsu and M. Katakawa for technical assistance.
###end p 80
###begin article-title 81
Immunological aspects of allergic asthma
###end article-title 81
###begin article-title 82
###xml 108 113 <span type="species:ncbi:10090">mouse</span>
Role of dendritic cells and Th2 lymphocytes in asthma: lessons from eosinophilic airway inflammation in the mouse
###end article-title 82
###begin article-title 83
###xml 81 89 <span type="species:ncbi:9606">patients</span>
Increased numbers of dendritic cells in the bronchial mucosa of atopic asthmatic patients: downregulation by inhaled corticosteroids
###end article-title 83
###begin article-title 84
Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness
###end article-title 84
###begin article-title 85
Eosinophilic inflammation in asthma
###end article-title 85
###begin article-title 86
Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response
###end article-title 86
###begin article-title 87
Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma
###end article-title 87
###begin article-title 88
###xml 89 95 <span type="species:ncbi:10090">murine</span>
Dissociation by steroids of eosinophilic inflammation from airway hyperresponsiveness in murine airways
###end article-title 88
###begin article-title 89
###xml 115 130 <span type="species:ncbi:10090">transgenic mice</span>
Marked airway eosinophilia prevents development of airway hyper-responsiveness during an allergic response in IL-5 transgenic mice
###end article-title 89
###begin article-title 90
###xml 70 76 <span type="species:ncbi:10090">murine</span>
Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity
###end article-title 90
###begin article-title 91
###xml 97 101 <span type="species:ncbi:10090">mice</span>
A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5
###end article-title 91
###begin article-title 92
Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma
###end article-title 92
###begin article-title 93
The role of T lymphocytes in the pathogenesis of asthma
###end article-title 93
###begin article-title 94
Relationship between IL-4 and IL-5 mRNA expression and disease severity in atopic asthma
###end article-title 94
###begin article-title 95
The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences
###end article-title 95
###begin article-title 96
###xml 23 25 23 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 13 19 <span type="species:ncbi:10090">murine</span>
Depletion of murine CD4+ T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia
###end article-title 96
###begin article-title 97
IL-4-independent induction of airway hyperresponsiveness by Th2, but not Th1, cells
###end article-title 97
###begin article-title 98
Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation
###end article-title 98
###begin article-title 99
###xml 120 125 <span type="species:ncbi:10090">mouse</span>
Early interleukin 4-dependent response can induce airway hyperreactivity before development of airway inflammation in a mouse model of asthma
###end article-title 99
###begin article-title 100
A novel role of cysteinyl leukotrienes to promote dendritic cell activation in the antigen-induced immune responses in the lung
###end article-title 100
###begin article-title 101
###xml 67 73 <span type="species:ncbi:10090">murine</span>
Diesel exhaust particulate induces airway hyperresponsiveness in a murine model: essential role of GM-CSF
###end article-title 101
###begin article-title 102
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse model of airway remodeling: strain differences
###end article-title 102
###begin article-title 103
###xml 63 69 <span type="species:ncbi:10090">murine</span>
Hepatocyte growth factor attenuates collagen accumulation in a murine model of pulmonary fibrosis
###end article-title 103
###begin article-title 104
###xml 20 46 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 154 160 <span type="species:ncbi:10090">murine</span>
Ovalbumin (OVA) and Mycobacterium tuberculosis bacilli cooperatively polarize anti-OVA T-helper (Th) cells toward a Th1-dominant phenotype and ameliorate murine tracheal eosinophilia
###end article-title 104
###begin article-title 105
Bronchial responsiveness to mite allergen in atopic dermatitis without asthma
###end article-title 105
###begin article-title 106
###xml 61 65 <span type="species:ncbi:10090">mice</span>
Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography
###end article-title 106
###begin article-title 107
###xml 101 105 <span type="species:ncbi:10090">mice</span>
Unrestrained plethysmography is an unreliable measure of airway responsiveness in BALB/c and C57BL/6 mice
###end article-title 107
###begin article-title 108
###xml 91 95 <span type="species:ncbi:10090">mice</span>
Temporal correlation of measurements of airway hyperresponsiveness in ovalbumin-sensitized mice
###end article-title 108
###begin article-title 109
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
Hyperoxia-induced changes in mouse lung mechanics: forced oscillations vs. barometric plethysmography
###end article-title 109
###begin article-title 110
###xml 21 25 <span type="species:ncbi:10090">mice</span>
Interpreting Penh in mice
###end article-title 110
###begin article-title 111
###xml 66 70 <span type="species:ncbi:10090">mice</span>
A reevaluation of the validity of unrestrained plethysmography in mice
###end article-title 111
###begin article-title 112
###xml 54 59 <span type="species:ncbi:10090">mouse</span>
Visualization of early APC/T cell interactions in the mouse lung following intranasal challenge
###end article-title 112
###begin article-title 113
A restricted subset of dendritic cells captures airborne antigens and remains able to activate specific T cells long after antigen exposure
###end article-title 113
###begin article-title 114
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
###end article-title 114
###begin article-title 115
Visualizing the generation of memory CD4 T cells in the whole body
###end article-title 115
###begin article-title 116
Heterogeneity of the memory CD4 T cell response: persisting effectors and resting memory T cells
###end article-title 116
###begin article-title 117
###xml 83 85 83 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 90 94 90 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 98 100 98 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
An adoptive transfer model of allergic lung inflammation in mice is mediated by CD4+ CD62Llow CD25+ T cells
###end article-title 117
###begin article-title 118
###xml 76 80 <span type="species:ncbi:10090">mice</span>
T-lymphocytes regulate genetically determined airway hyperresponsiveness in mice
###end article-title 118
###begin article-title 119
###xml 39 43 <span type="species:ncbi:10090">mice</span>
Baseline airway hyperreactivity in A/J mice is not mediated by cells of the adaptive immune system
###end article-title 119
###begin article-title 120
###xml 107 111 <span type="species:ncbi:10090">mice</span>
Allergen-induced airway inflammation and bronchial responsiveness in wild-type and interleukin-4-deficient mice
###end article-title 120
###begin article-title 121
###xml 77 82 <span type="species:ncbi:9606">human</span>
Selective induction of eotaxin release by interleukin-13 or interleukin-4 in human airway smooth muscle cells is synergistic with interleukin-1beta and is mediated by the interleukin-4 receptor alpha-chain
###end article-title 121
###begin article-title 122
###xml 39 44 <span type="species:ncbi:9606">human</span>
IL-13 and IL-4 promote TARC release in human airway smooth muscle cells: role of IL-4 receptor genotype
###end article-title 122
###begin article-title 123
Immune mechanisms of smooth muscle hyperreactivity in asthma
###end article-title 123
###begin article-title 124
Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity
###end article-title 124
###begin article-title 125
###xml 3 6 3 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink">pos</sup>
###xml 13 17 13 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink">pos </sup>
CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3
###end article-title 125
###begin article-title 126
Cutting edge: invariant Valpha14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model
###end article-title 126
###begin article-title 127
###xml 14 15 14 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 18 20 18 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
Cultured NK1.1+CD4+ T cells produce large amounts of IL-4 and IFN-gamma upon activation by anti-CD3 or CD1
###end article-title 127

